Wordt geladen...
Should We Fear Resistance from Tenofovir/Emtricitabine PrEP?
PURPOSE OF REVIEW: To review current data on HIV-1 resistance arising from the use of fixed dose combination tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection. RECENT FINDINGS: Resistance to tenofovir (TNV) or FTC is infrequently sel...
Bewaard in:
| Gepubliceerd in: | Curr Opin HIV AIDS |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970748/ https://ncbi.nlm.nih.gov/pubmed/26633640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0000000000000209 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|